Hall Steven Edward

10% owner at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
Director at Dare Bioscience, Inc. · on record since Apr 15, 2014
10% owner at Dare Bioscience, Inc. · on record since Apr 15, 2014
10% owner at AMERICAN LEARNING Corp · on record since Jun 28, 2017
Former 10% owner at AMERICAN LEARNING Corp · on record since Jul 7, 2017
10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
Director at Forma Therapeutics Holdings, Inc. · on record since Jun 22, 2020
Director at Kymera Therapeutics, Inc. · on record since Aug 25, 2020

Insider trading activity of Hall Steven Edward

Transactions on record: 22; since Apr 15, 2014

Open-market buys: 2; $9.1M

Open-market sells: 0

Companies traded: 4; last filing Jun 17, 2021

Figures computed from official regulatory filings — .

Companies where Hall Steven Edward has traded

Kymera Therapeutics, Inc.5 tx · Jun 17, 2021
Forma Therapeutics Holdings, Inc.4 tx · Nov 25, 2020
Surface Oncology, Inc.3 tx · $4M · Apr 23, 2018
Dare Bioscience, Inc.10 tx · $5.1M · Jun 30, 2015

Track record of Hall Steven Edward

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hall Steven Edward

Co-insiders of Hall Steven Edward

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jun 17, 2021	AwardD (derivative)	20,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	Other	2,106,828	—	n/a (No price was disclosed in the filing)		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	OtherD (derivative)	-3,178,630	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	OtherD (derivative)	-5,833,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	Other	2,192,249	—	n/a (No price was disclosed in the filing)		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	OtherD (derivative)	-985,220	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	OtherD (derivative)	-2,511,198	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 21, 2020	AwardD (derivative)	40,127	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Jun 22, 2020	AwardD (derivative)	17,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	OtherD (derivative)	-7,000,000	—	n/a (No price was disclosed in the filing)		SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	conv 53ClusterFirst in 12mo	SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	Other	3,181,817	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Jun 30, 2015	AwardD (derivative)	11,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	-13,513,513	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	192,209	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	199,875	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Buy	733,445	7.00 USD	$5.1M	conv 59ClusterFirst in 12mo	SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	-4,340,831	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	299,213	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	931,485	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jun 17, 2021	AwardD (derivative)	20,063	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	Other	2,106,828	—	n/a (No price was disclosed in the filing)		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	OtherD (derivative)	-3,178,630	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Nov 25, 2020	OtherD (derivative)	-5,833,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	Other	2,192,249	—	n/a (No price was disclosed in the filing)		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	OtherD (derivative)	-985,220	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 25, 2020	OtherD (derivative)	-2,511,198	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Aug 21, 2020	AwardD (derivative)	40,127	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Forma Therapeutics Holdings, Inc.Listing unverified	Jun 22, 2020	AwardD (derivative)	17,533	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	OtherD (derivative)	-7,000,000	—	n/a (No price was disclosed in the filing)		SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	conv 53ClusterFirst in 12mo	SEC
Surface Oncology, Inc.Listing unverified	Apr 23, 2018	Other	3,181,817	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Jun 30, 2015	AwardD (derivative)	11,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	-13,513,513	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	192,209	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	0	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	199,875	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Buy	733,445	7.00 USD	$5.1M	conv 59ClusterFirst in 12mo	SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	OtherD (derivative)	-4,340,831	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	299,213	—	n/a (No price was disclosed in the filing)		SEC
Dare Bioscience, Inc.Listing on record	Apr 15, 2014	Other	931,485	—	n/a (No price was disclosed in the filing)		SEC